Provided by Morgan, Lewis & Bockius LLP
The intersection of business, science, and the law poses unique challenges for life sciences companies. Morgan Lewis understands the ramifications of that critical connection, and our lawyers work efficiently and strategically to solve the business, transactional, regulatory, intellectual property, litigation, and related issues our clients encounter throughout the product life cycle.
Our global life sciences capabilities were developed specifically to serve the pharmaceutical, biotechnology, medical device, and related industries, as well as the entities that invest in them, such as venture capital and private equity funds.
Provided by Chambers
Morgan, Lewis & Bockius represented Merck in its global development and commercialization agreement for three of Daiichi Sankyo’s antibody-drug conjugate candidates.
Provided by Chambers
Morgan Lewis does an excellent of job getting to know our business so that it can effectively negotiate meaningful and pragmatic agreements for us.
The firm has strong commitment and creativity, and has been a terrific partner. The team is always ready and willing to help.
I would highlight the firm's professionalism, experience and attention to detail. Morgan Lewis is a valuable partner that provides us an excellent service.
Morgan Lewis attorneys are very smart, insightful thinkers, who provide clear explanations and logical planning.
Morgan Lewis does an excellent of job getting to know our business so that it can effectively negotiate meaningful and pragmatic agreements for us.
The firm has strong commitment and creativity, and has been a terrific partner. The team is always ready and willing to help.
I would highlight the firm's professionalism, experience and attention to detail. Morgan Lewis is a valuable partner that provides us an excellent service.
Morgan Lewis attorneys are very smart, insightful thinkers, who provide clear explanations and logical planning.
Provided by Chambers
Alan Leeds adeptly advises large pharmaceutical companies on strategic collaborations and transactions. Alan leads the firm’s life sciences transactions practice.
David Glazer's respected life sciences practice sees him advise market leading and innovative companies on M&A transactions, strategic partnerships and collaboration agreements.
David is a valuable partner and I enjoy working with him.
David Glazer is very skilled at handling complex agreements.
David Schwartz has a varied practice of commercial maters. Life sciences clients call upon David for his financing, investment, transactional and collaboration expertise.
David is very responsive and takes the time to understand the business.
Dave is wonderful to work with.